ARCH Venture Partners
VC🇺🇸 United StatesInvestment thesis
Science-first, contrarian investor that co-founds companies at the concept stage by identifying breakthrough science, recruiting management teams and providing patient capital. Sizes investments to the opportunity rather than fund constraints.
Notable portfolio
IlluminaAlnylam PharmaceuticalsBluebird Bio
Sector focus
Life sciencesBiotechTherapeuticsPrecision medicineDiagnosticsDeep science